Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer Academic Article uri icon

Overview

MeSH Major

  • CD8-Positive T-Lymphocytes
  • Chromatin
  • Neoplasms

abstract

  • Baseline corticosteroid use of ≥ 10 mg of prednisone equivalent was associated with poorer outcome in patients with non-small-cell lung cancer who were treated with PD-(L)1 blockade. Prudent use of corticosteroids at the time of initiating PD-(L)1 blockade is recommended.

publication date

  • October 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2018.79.0006

PubMed ID

  • 30125216

Additional Document Info

start page

  • 2872

end page

  • 2878

volume

  • 36

number

  • 28